Stocktoria
Core Scientific, Inc./tx CORZ
Nasdaq · XNAS · stock · Finance Services · website · IPO 2021-04-05
Core Scientific, Inc./tx statistics & valuation
Market cap$8.6B
P / S27.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% |
| Operating margin | -77.0% | -27.8% | 1.8% | -329.5% | 24.2% |
| Net margin | -90.5% | -281.6% | -49.1% | -335.2% | 8.7% |
| FCF margin | -141.3% | -10.2% | 9.7% | -27.9% | -10.4% |
| Return on assets | -12.3% | -97.4% | -34.6% | -265.7% | 1.9% |
| Return on equity | 30.0% | 152.5% | 41.3% | 524.3% | 3.5% |
| Debt / equity | -1.10× | — | — | — | — |
| Current ratio | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 |
| Revenue growth | -37.5% | 1.6% | -21.5% | 17.6% | 802.7% |
Source: SEC EDGAR filings · CIK 0001839341 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.